SICA, Antonio
 Distribuzione geografica
Continente #
EU - Europa 6.638
NA - Nord America 5.186
AS - Asia 3.616
SA - Sud America 771
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 12
Totale 16.338
Nazione #
US - Stati Uniti d'America 5.064
RU - Federazione Russa 1.528
IE - Irlanda 1.301
SG - Singapore 1.145
DE - Germania 917
CN - Cina 791
SE - Svezia 767
IT - Italia 634
HK - Hong Kong 618
BR - Brasile 590
UA - Ucraina 566
VN - Vietnam 511
FI - Finlandia 301
FR - Francia 231
GB - Regno Unito 122
IN - India 122
KR - Corea 107
EE - Estonia 86
ID - Indonesia 75
AR - Argentina 73
CA - Canada 55
MX - Messico 51
TR - Turchia 49
BD - Bangladesh 44
AT - Austria 42
ZA - Sudafrica 33
PL - Polonia 29
BE - Belgio 27
EC - Ecuador 27
IQ - Iraq 26
JP - Giappone 23
NL - Olanda 23
ES - Italia 21
CO - Colombia 20
BJ - Benin 19
PY - Paraguay 15
EU - Europa 13
VE - Venezuela 13
AU - Australia 12
CL - Cile 12
PK - Pakistan 12
MA - Marocco 11
TW - Taiwan 11
EG - Egitto 10
PH - Filippine 10
SA - Arabia Saudita 10
KZ - Kazakistan 9
PE - Perù 9
CZ - Repubblica Ceca 8
UY - Uruguay 8
DZ - Algeria 7
LT - Lituania 7
TN - Tunisia 7
UZ - Uzbekistan 7
DK - Danimarca 6
MY - Malesia 6
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
LB - Libano 4
PS - Palestinian Territory 4
PT - Portogallo 4
AL - Albania 3
BO - Bolivia 3
CH - Svizzera 3
MT - Malta 3
NP - Nepal 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
ET - Etiopia 2
GE - Georgia 2
IL - Israele 2
LV - Lettonia 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
NO - Norvegia 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
Totale 16.338
Città #
Dublin 1.297
Jacksonville 958
Hong Kong 609
Dearborn 465
Chandler 353
Singapore 346
San Jose 319
Ashburn 302
Wilmington 235
Beijing 223
Moscow 202
Piemonte 195
Bremen 177
Lawrence 176
Princeton 176
Ho Chi Minh City 171
Lauterbourg 160
San Mateo 146
Los Angeles 125
Ann Arbor 118
Andover 113
Hanoi 94
Seoul 93
Buffalo 85
São Paulo 58
Düsseldorf 57
New York 50
Milan 49
Orem 49
Novara 47
Boardman 44
Munich 44
Santa Clara 38
Guangzhou 36
Woodbridge 35
Frankfurt am Main 34
Dong Ket 32
Nuremberg 32
Hefei 31
Houston 31
Jakarta 31
Redondo Beach 31
Dallas 30
Nanjing 27
Da Nang 26
Haiphong 24
Norwalk 24
Philadelphia 24
Tianjin 24
Chennai 23
Council Bluffs 22
Helsinki 22
Tokyo 21
Warsaw 21
Brooklyn 20
Brussels 20
Hangzhou 20
Cotonou 19
Mexico City 19
Atlanta 18
Poplar 18
Shanghai 18
London 16
Montreal 16
Rio de Janeiro 16
Turin 16
Vienna 16
Denver 15
Stockholm 15
Toronto 15
Amsterdam 14
Kunming 14
Mumbai 14
Johannesburg 13
Boston 12
Dhaka 11
Fairfield 11
Hải Dương 11
New Delhi 11
Porto Alegre 11
Asunción 10
Falkenstein 10
Guayaquil 10
Manchester 10
Ninh Bình 10
Baghdad 9
Biên Hòa 9
Brasília 9
Casalecchio Di Reno 9
Kocaeli 9
Manaus 9
Nichelino 8
Recife 8
San Francisco 8
Thái Bình 8
Zhengzhou 8
Ankara 7
Belo Horizonte 7
Cassano Magnago 7
Changsha 7
Totale 8.726
Nome #
Cancer immunity and immunotherapy beyond COVID-19 212
Heme catabolism by tumor-associated macrophages controls metastasis formation 170
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection 167
Nicotinamide Phosphoribosyltransferase (NAMPT) acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 166
The p50 NF-κB subunit is a prognostic regulator of colorectal cancer-associated inflammation 159
Macrophage polarization in pathology 154
(0) Save to: more options FUNCTIONAL INTERACTION OF NF-KAPPA-B WITH INTERFERON-GAMMA GENOMIC DNA - IDENTIFICATION OF MULTIPLE NF-KAPPA-B AND NF-AT BINDING-SITES 149
Inflammaging and Osteoarthritis. 146
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis 138
Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies 137
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors: novel modulators of antitumor immunity 136
Functions of diverse myeloid cells in the tumor micro-environment 133
Pro-tumor steering of cancer inflammation by p50 NF-κB enhances colorectal cancer progression 132
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 132
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 128
Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC. 127
The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance 124
Molecular and epigenetic basis of macrophage polarized activation 123
A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF-{kappa}B and enhanced IRF-3/STAT1 activation 121
Metabolic regulation of suppressive myeloid cells in cancer 121
Tumor-associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy 121
Metabolic influence on the differentiation of suppressive myeloid cells in cancer. 120
Cancer-related Inflammation 119
Hypoxia-mediated regulation of macrophage functions in pathophysiology 118
The role of cytokines as communication signals between leukocytes and endothelial cells. 115
A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). 115
Myeloid-derived suppressor cells: Ductile targets in disease 115
Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages 113
Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. 112
AIRE modulates IFN- expression in T lymphocytes 112
Bacterial lipopolisaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes 112
Hypoxia-mediated regulation of macrophage functions in pathophysiology. 111
Immunometabolic interference between cancer and COVID-19 111
Macrophage polarization in tumour progression 110
A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization 110
Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. 109
Interaction of NF-kB and NFAT with the Interferon-gamma Promoter 108
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. 107
LPS-tolerant monocytes/macrophages express a distinct M2 functional profile 107
Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells 107
A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. 106
IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member in Trypanosoma congolense infection-resistant C57BL/6 mice 105
ALTERATIONS IN NF-KAPPA-B/REL FAMILY PROTEINS IN SPLENIC T-CELLS FROM TUMOR-BEARING MICE AND REVERSAL FOLLOWING THERAPY 102
Autocrine production of interleukin-10 (IL-10) mediates defective IL-12 production and NF-kappa B activation in tumor associated macrophages 101
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors are novel modulators of myeloid-derived suppressor cells 101
Influence of innate immunity on cancer cell stemness 100
Interleukin-6 gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae. 99
Endothelial cells express the interleukin-1 receptor type I. 99
Oncolytic virotherapy: new weapon for breast cancer treatment 99
Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. 98
Cellular and molecular pathways linking inflammation and cancer 98
Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. 98
Targeting cancer cells and tumor microenvironment in preclinical and clinical models of Hodgkin lymphoma using the dual PI3Kd/G inhibitor RP6530 98
convergent pathways of macrophage polarization: the role of B cells 97
Inflammation and cancer: breast cancer as a prototype 97
Lipid metabolism and cancer immunotherapy: Immunosuppressive myeloid cells at the crossroad 96
IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. 95
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene 95
Inflammation as target in cancer therapy 95
Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema. 93
Altered macrophage differentiation and immune dysfunctions during tumor development 93
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target. 93
NF-kappa B p50 regulates mast cell survival in part through upregulation of miR-146a 92
The p50 subunit of NF-?B orchestrates dendritic cell lifespan and activation of adaptive immunity. 92
High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone. 91
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. 91
MiR-146a and NF-kB1 regulate mast cell survival and T lymphocyte differentiation 90
Nicotinamide Phosphorybosyltransferase (NAMPT) Inhibitors are Novel Modulator of Cancer-Related Inflammation 90
Expression of c-jun protooncogene in human myelomonocytic cells. 90
SPARC is a new myeloid-derived suppressor cell marker licensing suppressive activities 90
Murine endothelioma cell lines transformed by polyoma middle T oncogene as target for and producers of cytokines. 89
Cancer related inflammation: the macrophage connection. 89
Frailty in Rheumatic Diseases 89
GADD45β loss ablates innate immunosuppression in cancer 88
Negative transcriptional regulation of the interferon-gamma promoter by glucocorticoids and dominant negative mutants of c-Jun. 87
Autocrine production of Interleukin-10 (IL-10) mediates defective IL-12 production and NF-kB activation in Tumor Associated Macrophages 86
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors 86
IDENTIFICATION OF NOVEL PROTEIN-BINDING SEQUENCES IN THE 1ST INTRON OF HUMAN INTERFERON-GAMMA-GENOMIC DNA 85
Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. 85
Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor. 85
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective. 84
NF-KAPPA-B AND A P120 INTERACT WITH THE IFN-GAMMA INTRONIC CREL BINDING-SITE C3 84
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. 84
Defective expressione of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma 84
MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. 83
Mechanisms linking pathogens-associated inflammation and cancer 83
Macrophage activation and polarization. 83
Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs) 83
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. 83
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy. 83
Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases 83
RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression 82
Precision Medicine Approaches with Metabolomics and Artificial Intelligence 82
Linking inflammation reactions to cancer: novel targets for therapeutic strategies. 82
Macrophage activation and polarization as an adaptive component of innate immunity 82
Immunometabolic status of covid-19 cancer patients 82
Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology 81
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. 81
Suppressor of cytokine signaling (SOCS) 2 and 3: diametrically control macrophage polarisation 80
Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgery 80
Totale 10.529
Categoria #
all - tutte 78.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.718


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021368 0 0 0 0 0 0 0 0 0 90 210 68
2021/20221.276 36 5 271 200 47 20 129 16 88 19 180 265
2022/20232.775 199 114 121 103 331 244 42 173 1.321 8 77 42
2023/2024757 56 48 74 22 134 16 201 27 4 9 40 126
2024/20252.293 54 12 123 72 50 97 190 247 572 339 148 389
2025/20265.565 201 229 569 1.078 526 436 736 992 450 348 0 0
Totale 16.469